Review
The emerging role of monoclonal antibodies in the clinical management of epithelial ovarian carcinoma
- PMID: 3331386
Item in Clipboard
Review
The emerging role of monoclonal antibodies in the clinical management of epithelial ovarian carcinoma
Important Adv Oncol.
1987.
No abstract available
Similar articles
-
Ovarian carcinoma therapy with monoclonal antibodies.Hybridoma. 1993 Oct;12(5):501-7. doi: 10.1089/hyb.1993.12.501. Hybridoma. 1993. PMID: 8300122 Review. No abstract available.
-
Immunodiagnosis of ovarian tumors.Immunol Ser. 1990;53:323-38. Immunol Ser. 1990. PMID: 2100566 Review. No abstract available.
-
Antitumor antibodies for immunotherapy of ovarian carcinomas.Hybridoma. 1993 Oct;12(5):521-8. doi: 10.1089/hyb.1993.12.521. Hybridoma. 1993. PMID: 8300125 Clinical Trial. No abstract available.
-
[Possibilities and limitations of the clinical use of specific monoclonal antibodies for epithelial ovarian carcinomas: CA125K].Minerva Ginecol. 1985 May;37(5):253-7. Minerva Ginecol. 1985. PMID: 3861960 Italian. No abstract available.
-
[REGAJ diagnosis of recurrence of ovarian cancer].Gynakol Rundsch. 1989;29 Suppl 2:360-3. Gynakol Rundsch. 1989. PMID: 2613050 German. No abstract available.
Cited by
-
Distribution of radiolabelled anti-CA125 monoclonal antibody OC125-F(ab)2-fragment following resection guided by antibodies (REGAJ) in ovarian cancer patients.J Clin Lab Anal. 1997;11(2):94-103. doi: 10.1002/(SICI)1098-2825(1997)11:2<94::AID-JCLA5>3.0.CO;2-K. J Clin Lab Anal. 1997. PMID: 9058243 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical